Vita Life Sciences Ltd (VLS) - Total Liabilities

Latest as of June 2025: AU$22.03 Million AUD ≈ $15.59 Million USD

Based on the latest financial reports, Vita Life Sciences Ltd (VLS) has total liabilities worth AU$22.03 Million AUD (≈ $15.59 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore VLS cash flow conversion to assess how effectively this company generates cash.

Vita Life Sciences Ltd - Total Liabilities Trend (2000–2024)

This chart illustrates how Vita Life Sciences Ltd's total liabilities have evolved over time, based on quarterly financial data. Check VLS cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Vita Life Sciences Ltd Competitors by Total Liabilities

The table below lists competitors of Vita Life Sciences Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Ablerex Electronics Co Ltd TWO:3628	Taiwan	NT$1.81 Billion
Papaya Growth Opportunity Corp I NASDAQ:PPYA	USA	$24.32 Million
Genovate Biotechnology Co Ltd TWO:4130	Taiwan	NT$126.05 Million
NCS Multistage Holdings Inc NASDAQ:NCSM	USA	$34.91 Million
Dhunseri Ventures Limited NSE:DVL	India	Rs11.30 Billion
Pinar Sut Mamulleri Sanayi AS IS:PNSUT	Turkey	TL9.48 Billion
Miwon Holdings Co. Ltd KO:107590	Korea	₩210.05 Billion
Bioton S.A. WAR:BIO	Poland	zł175.74 Million

Liability Composition Analysis (2000–2024)

This chart breaks down Vita Life Sciences Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Vita Life Sciences Ltd (VLS) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.94	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	1.46	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.42	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vita Life Sciences Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vita Life Sciences Ltd (2000–2024)

The table below shows the annual total liabilities of Vita Life Sciences Ltd from 2000 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$19.61 Million ≈ $13.87 Million	+19.02%
2023-12-31	AU$16.48 Million ≈ $11.66 Million	+7.71%
2022-12-31	AU$15.30 Million ≈ $10.82 Million	+3.02%
2021-12-31	AU$14.85 Million ≈ $10.51 Million	+1.27%
2020-12-31	AU$14.66 Million ≈ $10.37 Million	+4.88%
2019-12-31	AU$13.98 Million ≈ $9.89 Million	+5.00%
2018-12-31	AU$13.31 Million ≈ $9.42 Million	+63.13%
2017-12-31	AU$8.16 Million ≈ $5.77 Million	-11.14%
2016-12-31	AU$9.18 Million ≈ $6.50 Million	-3.45%
2015-12-31	AU$9.51 Million ≈ $6.73 Million	+9.26%
2014-12-31	AU$8.71 Million ≈ $6.16 Million	+51.67%
2013-12-31	AU$5.74 Million ≈ $4.06 Million	+4.92%
2012-12-31	AU$5.47 Million ≈ $3.87 Million	+24.54%
2011-12-31	AU$4.39 Million ≈ $3.11 Million	-31.17%
2010-12-31	AU$6.38 Million ≈ $4.52 Million	+30.01%
2009-12-31	AU$4.91 Million ≈ $3.47 Million	+2.38%
2008-12-31	AU$4.79 Million ≈ $3.39 Million	+24.56%
2007-12-31	AU$3.85 Million ≈ $2.72 Million	-58.89%
2006-12-31	AU$9.36 Million ≈ $6.62 Million	-68.51%
2005-12-31	AU$29.73 Million ≈ $21.04 Million	+1.80%
2004-12-31	AU$29.21 Million ≈ $20.67 Million	+0.97%
2003-12-31	AU$28.92 Million ≈ $20.47 Million	+39.80%
2002-12-31	AU$20.69 Million ≈ $14.64 Million	-20.03%
2001-12-31	AU$25.87 Million ≈ $18.30 Million	+29.32%
2000-12-31	AU$20.00 Million ≈ $14.15 Million	--

About Vita Life Sciences Ltd

AU:VLS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$98.16 Million

AU$138.74 Million AUD

Market Cap Rank

#19259 Global

#630 in Australia

Share Price

AU$2.54

Change (1 day)

-0.39%

52-Week Range

AU$1.76 - AU$2.83

All Time High

AU$2.83